IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Glenmark Life Sciences Limited is an Pharmaceutical based company, located in Solapur, Glenmark Life Sciences Limited IPO size was 1513.60 Cr. and was issued at 720.00 per share. The share of Glenmark Life Sciences Limited were listed at 748.20 per share and are currently trading at 1011.85 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
Glenmark Life Sciences operates in Pharmaceutical and Developer And Manufacturer. The Issue is listed on MainBoard in Aug, 2021. Glenmark Life Sciences IPO size was 1513.60 Cr. with Issue price of 720.00 .
Merchant Banker(s) of Glenmark Life Sciences IPO: Bob Capital Markets Limited , Bofa Securities India Limited , Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , Goldman Sachs (India) Securities Private Limited
Glenmark Life Sciences IPO subscription was 44.17 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Glenmark Life Sciences IPO listed at a listing price of 748.20 against the offer price of 720.00.
The current market price of Glenmark Life Sciences is 1011.85.
Why Us?
